enoxacin has been researched along with Cronobacter Infections in 4 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-one patients with serious or complicated urinary tract infections were treated with oral enoxacin for between four and eight days." | 7.67 | An open study of the safety and efficacy of enoxacin in complicated urinary tract infections. ( Bates, S; Foot, M; Quaghebeur, G; Roe, M; Want, S; Williams, G, 1988) |
| "Thirty-one patients with serious or complicated urinary tract infections were treated with oral enoxacin for between four and eight days." | 3.67 | An open study of the safety and efficacy of enoxacin in complicated urinary tract infections. ( Bates, S; Foot, M; Quaghebeur, G; Roe, M; Want, S; Williams, G, 1988) |
| "Enoxacin was evaluated in in-vitro tests and in studies of effectiveness and blood concentrations in the mouse." | 1.27 | Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates. ( Bien, PA; Cohen, MA; Dombrowski, ME; Griffin, TJ; Heifetz, CL; Malta, TE; Sesnie, JC; Shapiro, MA; Wold, SA, 1988) |
| "Enoxacin at 100 mg/kg was significantly more effective than enoxacin at 25 mg/kg and cefoperazone." | 1.27 | Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis. ( Boscia, JA; Kaye, D; Kobasa, WD, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heifetz, CL | 1 |
| Bien, PA | 1 |
| Cohen, MA | 1 |
| Dombrowski, ME | 1 |
| Griffin, TJ | 1 |
| Malta, TE | 1 |
| Sesnie, JC | 1 |
| Shapiro, MA | 1 |
| Wold, SA | 1 |
| Foot, M | 1 |
| Williams, G | 1 |
| Want, S | 1 |
| Roe, M | 1 |
| Quaghebeur, G | 1 |
| Bates, S | 1 |
| Boscia, JA | 2 |
| Kobasa, WD | 2 |
| Kaye, D | 2 |
4 other studies available for enoxacin and Cronobacter Infections
| Article | Year |
|---|---|
Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
Topics: Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Enoxacin; Enterobacteriaceae; Enteroba | 1988 |
An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Evaluation; Enoxacin; Enterobacteriaceae Infections; Entero | 1988 |
Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Ente | 1987 |
Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Endocarditis, Bacterial; Enoxacin; Enterobacter; Enter | 1985 |